Indication

Plasmodium malariae malaria

Plasmodium malariae malaria is a parasitic infection of the red blood cells caused by the protozoan *Plasmodium malariae*, typically transmitted through the bite of an infected female *Anopheles* mosquito. Read more about Plasmodium malariae malaria

37 drugs 36 manufacturers

Advertisement

Drugs that treat it

Common Plasmodium malariae malaria therapies.

Showing 37–37 of 37 drugs

Filter & compare in the drug finder →Opens the drug finder with Plasmodium malariae malaria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Plasmodium malariae malaria.

Plasmodium malariae malaria is a parasitic infection of the red blood cells caused by the protozoan *Plasmodium malariae*, typically transmitted through the bite of an infected female *Anopheles* mosquito.

The disease primarily affects the hematologic, reticuloendothelial, and renal systems in exposed or resident populations within endemic tropical and subtropical regions.

Pathophysiologically, the parasite preferentially infects older erythrocytes and completes a 72-hour asexual erythrocytic schizogony cycle, characteristically producing periodic "quartan" fever paroxysms alongside chills, headache, fatigue, splenomegaly, and anemia.

While it generally follows a milder, chronic course with low levels of parasitemia, long-standing or recrudescent infection can lead to immune-complex deposition in the kidneys, resulting in quartan malarial nephropathy and nephrotic syndrome.

Personalize your experience

Follow Plasmodium malariae malaria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it